- TRADE NAMES: Agilect; Azilect (Teva)
- INDICATIONS: Parkinsonism
- CLASS: Monoamine oxidase B inhibitor, Neuroprotectant
- HALF-LIFE: 0.6–2.0 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aminophylline, Amitriptyline, Ciprofloxacin, Citalopram, Dextromethorphan, Entacapone, Fluoxetine, Fluvoxamine, MAO inhibitors, Meperidine, Paroxetine Hydrochloride, Pethidine, Pseudoephedrine, SSRIs, Viloxazine
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see two reviews of rasagiline in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 05/08/2024
